Monoclonal Antibodies (MAbS) Global Market Report 2020

Publisher Name :
Date: 09-Dec-2019
No. of pages: 200

Monoclonal Antibodies (MAbS) Market Global Report 2020 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the global monoclonal antibodies (mabs) market.

Reasons to Purchase

- Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.

- Create regional and country strategies on the basis of local data and analysis.

- Identify growth segments for investment.

- Outperform competitors using forecast data and the drivers and trends shaping the market.

- Understand customers based on the latest market research findings.

- Benchmark performance against key competitors.

- Utilize the relationships between key data sets for superior strategizing.

- Suitable for supporting your internal and external presentations with reliable high quality data and analysis

- Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Description:

Where is the largest and fastest growing market for the monoclonal antibodies (mabs)? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Monoclonal Antibodies (MAbS) Market Global Report from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market.

- The Market Characteristics section of the report defines and explains the market.

- The Market Size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market.

- Market Segmentations break down market into sub markets.

- The Regional and Country section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.

- Competitive Landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.

- The Trends and Strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.

Scope

Markets Covered: 1) By Source: Murine, Chimeric, Humanized, Human 2) By Application: Anti-Cancer, Immunological, Anti-Infective Monoclonal Antibodies (MAbs), Neuropharmacological, Cardiovascular And Cerebrovascular, Others 3) By End Users: Hospitals, Private Clinics, Research Institute

Companies Mentioned: Johnson & Johnson, Merck, AbbVie, Amgen, Glaxosmithkline plc

Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA

Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Time Series: Five years historic and forecast.

Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Monoclonal Antibodies (MAbS) Global Market Report 2020

Table of Contents

1. Executive Summary
2. Monoclonal Antibodies  Market Characteristics
3. Monoclonal Antibodies  Market Size And Growth
3.1. Global Monoclonal Antibodies  Historic Market, 2015 - 2019, $ Billion
3.1.1. Drivers Of The Market
3.1.2. Restraints On The Market
3.2. Global Monoclonal Antibodies  Forecast Market, 2019 - 2022F, 2025F, 2030F, $ Billion
3.2.1. Drivers Of The Market
3.2.2. Restraints On the Market
4. Monoclonal Antibodies  Market Segmentation
4.1. Global Monoclonal Antibodies  Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Murine
Chimeric
Humanized
Human 
4.2. Global Monoclonal Antibodies  Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Anti-Cancer
Immunological
Anti-Infective Monoclonal Antibodies (MAbs)
Neuropharmacological
Cardiovascular And Cerebrovascular
Others
4.3. Global Monoclonal Antibodies  Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Hospitals
Private Clinics
Research Institute
5. Monoclonal Antibodies  Market Regional And Country Analysis
5.1. Global Monoclonal Antibodies  Market, Split By Region, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
5.2. Global Monoclonal Antibodies  Market, Split By Country, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
6. Asia-Pacific Monoclonal Antibodies  Market
6.1. Asia-Pacific Monoclonal Antibodies  Market Overview
6.2. Asia-Pacific Monoclonal Antibodies  Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
6.3. Asia-Pacific Monoclonal Antibodies  Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
6.4. Asia-Pacific Monoclonal Antibodies  Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
7. China Monoclonal Antibodies  Market
7.1. China Monoclonal Antibodies  Market Overview
7.2. China Monoclonal Antibodies  Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F,$ Billion
7.3. China Monoclonal Antibodies  Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F,$ Billion
7.4. China Monoclonal Antibodies  Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F,$ Billion
8. India Monoclonal Antibodies  Market
8.1. India Monoclonal Antibodies  Market Overview
8.2. India Monoclonal Antibodies  Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
8.3. India Monoclonal Antibodies  Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
8.4. India Monoclonal Antibodies  Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
9. Japan Monoclonal Antibodies  Market
9.1. Japan Monoclonal Antibodies  Market Overview
9.2. Japan Monoclonal Antibodies  Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
9.3. Japan Monoclonal Antibodies  Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
9.4. Japan Monoclonal Antibodies  Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
10. Australia Monoclonal Antibodies  Market
10.1. Australia Monoclonal Antibodies  Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
10.2. Australia Monoclonal Antibodies  Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
10.3. Australia Monoclonal Antibodies  Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
11. Indonesia Monoclonal Antibodies  Market
11.1. Indonesia Monoclonal Antibodies  Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
11.2. Indonesia Monoclonal Antibodies  Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
11.3. Indonesia Monoclonal Antibodies  Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
12. South Korea Monoclonal Antibodies  Market
12.1. South Korea Monoclonal Antibodies  Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
12.2. South Korea Monoclonal Antibodies  Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
12.3. South Korea Monoclonal Antibodies  Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
13. Western Europe Monoclonal Antibodies  Market
13.1. Western Europe Monoclonal Antibodies  Market Overview
13.2. Western Europe Monoclonal Antibodies  Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
13.3. Western Europe Monoclonal Antibodies  Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
13.4. Western Europe Monoclonal Antibodies  Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
14. UK Monoclonal Antibodies  Market
14.1. UK Monoclonal Antibodies  Market Overview
14.2. UK Monoclonal Antibodies  Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
14.3. UK Monoclonal Antibodies  Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
14.4. UK Monoclonal Antibodies  Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
15. Germany Monoclonal Antibodies  Market
15.1. Germany Monoclonal Antibodies  Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
15.2. Germany Monoclonal Antibodies  Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
15.3. Germany Monoclonal Antibodies  Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
16. France Monoclonal Antibodies  Market
16.5. France Monoclonal Antibodies  Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
16.6. France Monoclonal Antibodies  Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
16.7. France Monoclonal Antibodies  Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
17. Eastern Europe Monoclonal Antibodies  Market
17.1. Eastern Europe Monoclonal Antibodies  Market Overview
17.2. Eastern Europe Monoclonal Antibodies  Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
17.3. Eastern Europe Monoclonal Antibodies  Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
17.4. Eastern Europe Monoclonal Antibodies  Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
18. Russia Monoclonal Antibodies  Market
18.1. Russia Monoclonal Antibodies  Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
18.2. Russia Monoclonal Antibodies  Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
18.3. Russia Monoclonal Antibodies  Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
19. North America Monoclonal Antibodies  Market
19.1. North America Monoclonal Antibodies  Market Overview
19.2. North America Monoclonal Antibodies  Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
19.3. North America Monoclonal Antibodies  Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
19.4. North America Monoclonal Antibodies  Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
20. USA Monoclonal Antibodies  Market
20.1. USA Monoclonal Antibodies  Market Overview
20.2. USA Monoclonal Antibodies  Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
20.3. USA Monoclonal Antibodies  Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
20.4. USA Monoclonal Antibodies  Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
21. South America Monoclonal Antibodies  Market
21.1. South America Monoclonal Antibodies  Market Overview
21.2. South America Monoclonal Antibodies  Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
21.3. South America Monoclonal Antibodies  Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
21.4. South America Monoclonal Antibodies  Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
22. Brazil Monoclonal Antibodies  Market
22.1. Brazil Monoclonal Antibodies  Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
22.2. Brazil Monoclonal Antibodies  Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
22.3. Brazil Monoclonal Antibodies  Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
23. Middle East Monoclonal Antibodies  Market
23.1. Middle East Monoclonal Antibodies  Market Overview
23.2. Middle East Monoclonal Antibodies  Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
23.3. Middle East Monoclonal Antibodies  Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
23.4. Middle East Monoclonal Antibodies  Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
24. Africa Monoclonal Antibodies  Market
24.1. Africa Monoclonal Antibodies  Market Overview
24.2. Africa Monoclonal Antibodies  Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
24.3. Africa Monoclonal Antibodies  Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
24.4. Africa Monoclonal Antibodies  Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
25. Monoclonal Antibodies  Market Competitive Landscape And Company Profiles
25.1. Monoclonal Antibodies  Market Competitive Landscape
25.2. Monoclonal Antibodies  Market Company Profiles
25.2.1. Johnson & Johnson
25.2.1.1. Overview
25.2.1.2. Products and Services
25.2.1.3. Strategy
25.2.1.4. Financial Performance
25.2.2. Merck
25.2.2.1. Overview
25.2.2.2. Products and Services
25.2.2.3. Strategy
25.2.2.4. Financial Performance
25.2.3. AbbVie
25.2.3.1. Overview
25.2.3.2. Products and Services
25.2.3.3. Strategy
25.2.3.4. Financial Performance
25.2.4. Amgen
25.2.4.1. Overview
25.2.4.2. Products and Services
25.2.4.3. Strategy
25.2.4.4. Financial Performance
25.2.5. Glaxosmithkline plc
25.2.5.1. Overview
25.2.5.2. Products and Services
25.2.5.3. Strategy
25.2.5.4. Financial Performance
26. Key Mergers And Acquisitions In The Monoclonal Antibodies  Market
27. Monoclonal Antibodies  Market Trends And Strategies
28. Product Pipeline Analysis
29. Monoclonal Antibodies  Market Future Outlook and Potential Analysis
30. Appendix
30.1. Abbreviations
30.2. Currencies
30.3. Research Inquiries
30.4. The Business Research Company
30.5. Copyright And Disclaimer



List of Tables

Table 1: Global Historic Market Growth, 2015-2019, $ Billion
Table 2: Global Forecast Market Growth, 2015-2022F, 2025F, 2030F, $ Billion
Table 3: Global Monoclonal Antibodies  Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 4: Global Monoclonal Antibodies  Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 5: Global Monoclonal Antibodies  Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 6: Global Monoclonal Antibodies  Market, Split By Region, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 7: Global Monoclonal Antibodies  Market, Split By Country, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 8: Asia-Pacific, Monoclonal Antibodies  Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 9: Asia-Pacific, Monoclonal Antibodies  Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 10: Asia-Pacific, Monoclonal Antibodies  Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 11: China, Monoclonal Antibodies  Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 12: China, Monoclonal Antibodies  Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 13: China, Monoclonal Antibodies  Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 14: India, Monoclonal Antibodies  Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 15: India, Monoclonal Antibodies  Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 16: India, Monoclonal Antibodies  Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 17: Japan, Monoclonal Antibodies  Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 18: Japan, Monoclonal Antibodies  Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 19: Japan, Monoclonal Antibodies  Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 20: Australia, Monoclonal Antibodies  Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 21: Australia, Monoclonal Antibodies  Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 22: Australia, Monoclonal Antibodies  Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 23: Indonesia, Monoclonal Antibodies  Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 24: Indonesia, Monoclonal Antibodies  Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 25: Indonesia, Monoclonal Antibodies  Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 26: South Korea, Monoclonal Antibodies  Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 27: South Korea, Monoclonal Antibodies  Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 28: South Korea, Monoclonal Antibodies  Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 29: Western Europe, Monoclonal Antibodies  Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 30: Western Europe, Monoclonal Antibodies  Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 31: Western Europe, Monoclonal Antibodies  Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 32: UK, Monoclonal Antibodies  Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 33: UK, Monoclonal Antibodies  Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 34: UK, Monoclonal Antibodies  Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 35: Germany, Monoclonal Antibodies  Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 36: Germany, Monoclonal Antibodies  Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 37: Germany, Monoclonal Antibodies  Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 38: France, Monoclonal Antibodies  Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 39: France, Monoclonal Antibodies  Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 40: France, Monoclonal Antibodies  Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 41: Eastern Europe, Monoclonal Antibodies  Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 42: Eastern Europe, Monoclonal Antibodies  Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 43: Eastern Europe, Monoclonal Antibodies  Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 44: Russia, Monoclonal Antibodies  Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 45: Russia, Monoclonal Antibodies  Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 46: Russia, Monoclonal Antibodies  Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 47: North America, Monoclonal Antibodies  Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 48: North America, Monoclonal Antibodies  Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 49: North America, Monoclonal Antibodies  Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 50: USA, Monoclonal Antibodies  Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 51: USA, Monoclonal Antibodies  Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 52: USA, Monoclonal Antibodies  Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 53: South America, Monoclonal Antibodies  Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 54: South America, Monoclonal Antibodies  Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 55: South America, Monoclonal Antibodies  Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 56: Brazil, Monoclonal Antibodies  Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 57: Brazil, Monoclonal Antibodies  Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 58: Brazil, Monoclonal Antibodies  Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 59: Middle East, Monoclonal Antibodies  Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 60: Middle East, Monoclonal Antibodies  Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 61: Middle East, Monoclonal Antibodies  Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 62: Africa, Monoclonal Antibodies  Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 63: Africa, Monoclonal Antibodies  Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 64: Africa, Monoclonal Antibodies  Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 65: Johnson & Johnson Financial Performance
Table 66: Merck Financial Performance
Table 67: AbbVie Financial Performance
Table 68: Amgen Financial Performance
Table 69: Glaxosmithkline plc Financial Performance


List of Figures

Figure 1: Global Historic Market Growth, 2015-2019, $ Billion
Figure 2: Global Forecast Market Growth, 2015-2022F, 2025F, 2030F, $ Billion
Figure 3: Global Monoclonal Antibodies  Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 4: Global Monoclonal Antibodies  Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 5: Global Monoclonal Antibodies  Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 6: Global Monoclonal Antibodies  Market, Split By Region, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 7: Global Monoclonal Antibodies  Market, Split By Country, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 8: Asia-Pacific, Monoclonal Antibodies  Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 9: Asia-Pacific, Monoclonal Antibodies  Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 10: Asia-Pacific, Monoclonal Antibodies  Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 11: China, Monoclonal Antibodies  Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 12: China, Monoclonal Antibodies  Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 13: China, Monoclonal Antibodies  Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 14: India, Monoclonal Antibodies  Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 15: India, Monoclonal Antibodies  Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 16: India, Monoclonal Antibodies  Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 17: Japan, Monoclonal Antibodies  Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 18: Japan, Monoclonal Antibodies  Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 19: Japan, Monoclonal Antibodies  Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 20: Australia, Monoclonal Antibodies  Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 21: Australia, Monoclonal Antibodies  Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 22: Australia, Monoclonal Antibodies  Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 23: Indonesia, Monoclonal Antibodies  Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 24: Indonesia, Monoclonal Antibodies  Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 25: Indonesia, Monoclonal Antibodies  Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 26: South Korea, Monoclonal Antibodies  Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 27: South Korea, Monoclonal Antibodies  Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 28: South Korea, Monoclonal Antibodies  Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 29: Western Europe, Monoclonal Antibodies  Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 30: Western Europe, Monoclonal Antibodies  Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 31: Western Europe, Monoclonal Antibodies  Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 32: UK, Monoclonal Antibodies  Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 33: UK, Monoclonal Antibodies  Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 34: UK, Monoclonal Antibodies  Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 35: Germany, Monoclonal Antibodies  Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 36: Germany, Monoclonal Antibodies  Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 37: Germany, Monoclonal Antibodies  Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 38: France, Monoclonal Antibodies  Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 39: France, Monoclonal Antibodies  Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 40: France, Monoclonal Antibodies  Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 41: Eastern Europe, Monoclonal Antibodies  Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 42: Eastern Europe, Monoclonal Antibodies  Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 43: Eastern Europe, Monoclonal Antibodies  Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 44: Russia, Monoclonal Antibodies  Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 45: Russia, Monoclonal Antibodies  Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 46: Russia, Monoclonal Antibodies  Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 47: North America, Monoclonal Antibodies  Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 48: North America, Monoclonal Antibodies  Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 49: North America, Monoclonal Antibodies  Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 50: USA, Monoclonal Antibodies  Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 51: USA, Monoclonal Antibodies  Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 52: USA, Monoclonal Antibodies  Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 53: South America, Monoclonal Antibodies  Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 54: South America, Monoclonal Antibodies  Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 55: South America, Monoclonal Antibodies  Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 56: Brazil, Monoclonal Antibodies  Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 57: Brazil, Monoclonal Antibodies  Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 58: Brazil, Monoclonal Antibodies  Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 59: Middle East, Monoclonal Antibodies  Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 60: Middle East, Monoclonal Antibodies  Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 61: Middle East, Monoclonal Antibodies  Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 62: Africa, Monoclonal Antibodies  Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 63: Africa, Monoclonal Antibodies  Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 64: Africa, Monoclonal Antibodies  Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 65: Johnson & Johnson Financial Performance
Figure 66: Merck Financial Performance
Figure 67: AbbVie Financial Performance
Figure 68: Amgen Financial Performance
Figure 69: Glaxosmithkline plc Financial Performance
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs